{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:31Z","timestamp":1791273091852,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1038\/s41416-026-03550-7","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:01:08Z","timestamp":1784912468000},"page":"1220-1231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid metabolic reprogramming of macrophage by host APOBEC3 deficiency enhances anti-tumor immunity"],"prefix":"10.1038","volume":"135","author":[{"given":"Yuqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-5437","authenticated-orcid":false,"given":"Fanglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-4106","authenticated-orcid":false,"given":"Yiru","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-7238","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6617-9897","authenticated-orcid":false,"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-2543","authenticated-orcid":false,"given":"Bingshun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-4188","authenticated-orcid":false,"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"3550_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26:78.","journal-title":"J Biomed Sci"},{"key":"3550_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metab. 2019;30:36\u201350.","journal-title":"Cell Metab"},{"key":"3550_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19:369\u201382.","journal-title":"Nat Rev Immunol"},{"key":"3550_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101514","volume":"54","author":"P Ordentlich","year":"2021","unstructured":"Ordentlich P. Clinical evaluation of colony-stimulating factor 1 receptor inhibitors. Semin Immunol. 2021;54:101514.","journal-title":"Semin Immunol"},{"key":"3550_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening TM, Wang-Gillam A, Sanford DE, Belt BA, Panni RZ, Cusworth BM, et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 2016;17:651\u201362.","journal-title":"Lancet Oncol"},{"key":"3550_CR6","doi-asserted-by":"publisher","first-page":"1378647","DOI":"10.3389\/fonc.2024.1378647","volume":"14","author":"C Jiang","year":"2024","unstructured":"Jiang C, Sun H, Jiang Z, Tian W, Cang S, Yu J. Targeting the CD47\/SIRP\u03b1 pathway in malignancies: recent progress, difficulties and future perspectives. Front Oncol. 2024;14:1378647.","journal-title":"Front Oncol"},{"key":"3550_CR7","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood-2021-146547","volume":"138","author":"G Garcia-Manero","year":"2021","unstructured":"Garcia-Manero G, Erba HP, Sanikommu SR, Altman JK, Sayar H, Scott BL, et al. Evorpacept (ALX148), a CD47-blocking myeloid checkpoint inhibitor, in combination with azacitidine: a phase 1\/2 study in patients with myelodysplastic syndrome (ASPEN-02). Blood. 2021;138:2601.","journal-title":"Blood"},{"key":"3550_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O De Henau","year":"2016","unstructured":"De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman DH, et al. Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells. Nature. 2016;539:443\u20137.","journal-title":"Nature"},{"key":"3550_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","volume":"6","author":"R Jin","year":"2025","unstructured":"Jin R, Neufeld L, McGaha TL. Linking macrophage metabolism to function in the tumor microenvironment. Nat Cancer. 2025;6:239\u201352.","journal-title":"Nat Cancer"},{"key":"3550_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccell.2026.01.020","volume":"44","author":"X Sun","year":"2026","unstructured":"Sun X, Park MD, Merad M, Brown BD. Macrophages: Targets for next-generation cancer immunotherapy. Cancer Cell. 2026;44:498\u2013518.","journal-title":"Cancer Cell"},{"key":"3550_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","volume":"42","author":"C Bl\u00e9riot","year":"2024","unstructured":"Bl\u00e9riot C, Dunsmore G, Alonso-Curbelo D, Ginhoux F. A temporal perspective for tumor-associated macrophage identities and functions. Cancer Cell. 2024;42:747\u201358.","journal-title":"Cancer Cell"},{"key":"3550_CR12","doi-asserted-by":"publisher","first-page":"57693","DOI":"10.18632\/oncotarget.17027","volume":"8","author":"D Zhou","year":"2017","unstructured":"Zhou D, Yang K, Chen L, Zhang W, Xu Z, Zuo J, et al. Promising landscape for regulating macrophage polarization: epigenetic viewpoint. Oncotarget. 2017;8:57693\u2013706.","journal-title":"Oncotarget"},{"key":"3550_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11:750\u201361.","journal-title":"Nat Rev Immunol"},{"key":"3550_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7881","volume":"6","author":"S Sharma","year":"2015","unstructured":"Sharma S, Patnaik SK, Thomas Taggart R, Kannisto ED, Enriquez SM, Gollnick P, et al. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages. Nat Commun. 2015;6:6881.","journal-title":"Nat Commun"},{"key":"3550_CR15","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3390\/v7062757","volume":"7","author":"L Willems","year":"2015","unstructured":"Willems L, Gillet NA. APOBEC3 interference during replication of viral genomes. Viruses. 2015;7:2999\u20133018.","journal-title":"Viruses"},{"key":"3550_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/j.gastro.2018.03.027","volume":"155","author":"S Koh","year":"2018","unstructured":"Koh S, Kah J, Tham CYL, Yang N, Ceccarello E, Chia A, et al. Nonlytic lymphocytes engineered to express virus-specific T-cell receptors limit HBV infection by activating APOBEC3. Gastroenterology. 2018;155:180\u201393.e6.","journal-title":"Gastroenterology"},{"key":"3550_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14730-1","volume":"11","author":"B Zhu","year":"2020","unstructured":"Zhu B, Xiao Y, Yeager M, Clifford G, Wentzensen N, Cullen M, et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat Commun. 2020;11:886.","journal-title":"Nat Commun"},{"key":"3550_CR18","doi-asserted-by":"publisher","first-page":"e1008173","DOI":"10.1371\/journal.ppat.1008173","volume":"15","author":"Y Hakata","year":"2019","unstructured":"Hakata Y, Li J, Fujino T, Tanaka Y, Shimizu R, Miyazawa M. Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing. PLOS Pathog. 2019;15:e1008173.","journal-title":"PLOS Pathog"},{"key":"3550_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002;418:646\u201350.","journal-title":"Nature"},{"key":"3550_CR20","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.4049\/jimmunol.1501504","volume":"195","author":"S Stavrou","year":"2015","unstructured":"Stavrou S, Ross SR. APOBEC3 proteins in viral immunity. J Immunol. 2015;195:4565\u201370.","journal-title":"J Immunol"},{"key":"3550_CR21","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/ng.3670","volume":"48","author":"CD Middlebrooks","year":"2016","unstructured":"Middlebrooks CD, Banday AR, Matsuda K, Udquim K-I, Onabajo OO, Paquin A, et al. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat Genet. 2016;48:1330\u20138.","journal-title":"Nat Genet"},{"key":"3550_CR22","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1073\/pnas.1009687108","volume":"108","author":"R Susp\u00e8ne","year":"2011","unstructured":"Susp\u00e8ne R, Aynaud M-M, Gu\u00e9tard D, Henry M, Eckhoff G, Marchio A, et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci USA. 2011;108:4858\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, Alexandrov Ludmil B, Wedge David C, Van Loo P, Greenman Christopher D, Raine K, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979\u201393.","journal-title":"Cell"},{"key":"3550_CR24","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/nar\/gky1316","volume":"47","author":"JCF Ng","year":"2019","unstructured":"Ng JCF, Quist J, Grigoriadis A, Malim MH, Fraternali F. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases. Nucleic Acids Res. 2019;47:1178\u201394.","journal-title":"Nucleic Acids Res"},{"key":"3550_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/ajco.13107","volume":"15","author":"M Hashemi","year":"2019","unstructured":"Hashemi M, Moazeni-Roodi A, Taheri M. Association of APOBEC3 deletion with cancer risk: a meta-analysis of 26 225 cases and 37 201 controls. Asia Pac J Clin Oncol. 2019;15:275\u201387.","journal-title":"Asia Pac J Clin Oncol"},{"key":"3550_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-022-04398-6","volume":"602","author":"EN Bergstrom","year":"2022","unstructured":"Bergstrom EN, Luebeck J, Petljak M, Khandekar A, Barnes M, Zhang T, et al. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. Nature. 2022;602:510\u20137.","journal-title":"Nature"},{"key":"3550_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94\u2013101.","journal-title":"Nature"},{"key":"3550_CR28","doi-asserted-by":"publisher","first-page":"1550341","DOI":"10.1080\/2162402X.2018.1550341","volume":"8","author":"A Boichard","year":"2019","unstructured":"Boichard A, Pham TV, Yeerna H, Goodman A, Tamayo P, Lippman S, et al. APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. OncoImmunology. 2019;8:1550341.","journal-title":"OncoImmunology"},{"key":"3550_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s42003-020-01620-x","volume":"4","author":"EY Alqassim","year":"2021","unstructured":"Alqassim EY, Sharma S, Khan ANMNH, Emmons TR, Cortes Gomez E, Alahmari A, et al. RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization. Commun Biol. 2021;4:102.","journal-title":"Commun Biol"},{"key":"3550_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1651-1","volume":"20","author":"S Sharma","year":"2019","unstructured":"Sharma S, Wang J, Alqassim E, Portwood S, Cortes Gomez E, Maguire O, et al. Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells. Genome Biol. 2019;20:37.","journal-title":"Genome Biol"},{"key":"3550_CR31","doi-asserted-by":"publisher","first-page":"e20200261","DOI":"10.1084\/jem.20200261","volume":"217","author":"EK Law","year":"2020","unstructured":"Law EK, Levin-Klein R, Jarvis MC, Kim H, Argyris PP, Carpenter MA, et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. J Exp Med. 2020;217:e20200261.","journal-title":"J Exp Med"},{"key":"3550_CR32","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1530\/JME-19-0011","volume":"62","author":"NJ Smith","year":"2019","unstructured":"Smith NJ, Fenton TR. The APOBEC3 genes and their role in cancer: insights from human papillomavirus. J Mol Endocrinol. 2019;62:R269\u2013r87.","journal-title":"J Mol Endocrinol"},{"key":"3550_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/molbev\/msi026","volume":"22","author":"SG Conticello","year":"2004","unstructured":"Conticello SG, Thomas CJF, Petersen-Mahrt SK, Neuberger MS. Evolution of the AID\/APOBEC family of polynucleotide (Deoxy)cytidine deaminases. Mol Biol Evol. 2004;22:367\u201377.","journal-title":"Mol Biol Evol"},{"key":"3550_CR34","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1189\/jlb.0406249","volume":"80","author":"JP Edwards","year":"2006","unstructured":"Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 2006;80:1298\u2013307.","journal-title":"J Leukoc Biol"},{"key":"3550_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.imbio.2006.06.002","volume":"211","author":"JA Van Ginderachter","year":"2006","unstructured":"Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G, et al. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006;211:487\u2013501.","journal-title":"Immunobiology"},{"key":"3550_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","volume":"30","author":"J Yan","year":"2020","unstructured":"Yan J, Horng T. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 2020;30:979\u201389.","journal-title":"Trends Cell Biol"},{"key":"3550_CR37","doi-asserted-by":"publisher","first-page":"841249","DOI":"10.3389\/fcvm.2022.841249","volume":"9","author":"N Liu","year":"2022","unstructured":"Liu N, Guo Y-N, Wang X-J, Ma J, He Y-T, Zhang F, et al. Copy number analyses identified a novel gene: APOBEC3A related to lipid metabolism in the pathogenesis of preeclampsia. Front Cardiovasc Med. 2022;9:841249.","journal-title":"Front Cardiovasc Med"},{"key":"3550_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657\u201369.","journal-title":"Cell"},{"key":"3550_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis CA, Kimmelman AC. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 2017;27:863\u201375.","journal-title":"Trends Cell Biol"},{"key":"3550_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41590-018-0108-0","volume":"19","author":"S Kang","year":"2018","unstructured":"Kang S, Nakanishi Y, Kioi Y, Okuzaki D, Kimura T, Takamatsu H, et al. Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. Nat Immunol. 2018;19:561\u201370.","journal-title":"Nat Immunol"},{"key":"3550_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33349-y","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13:5782.","journal-title":"Nat Commun"},{"key":"3550_CR42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1039\/D1CB00076D","volume":"2","author":"B Wang","year":"2021","unstructured":"Wang B, Zhang X, Wang Y, Chen K, Wang F, Weng X, et al. One-pot fluorescent assay for sensitive detection of APOBEC3A activity. RSC Chem Biol. 2021;2:1201\u20135.","journal-title":"RSC Chem Biol"},{"key":"3550_CR43","doi-asserted-by":"publisher","first-page":"10535","DOI":"10.3390\/ijms231810535","volume":"23","author":"M Hern\u00e1ndez-Quiles","year":"2022","unstructured":"Hern\u00e1ndez-Quiles M, Baak R, Orea-Soufi A, Borgman A, den Haan S, Sobrevals Alcaraz P, et al. TRIB3 modulates PPAR\u03b3-mediated growth inhibition by interfering with the MLL complex in breast cancer cells. Int J Mol Sci. 2022;23:10535.","journal-title":"Int J Mol Sci"},{"key":"3550_CR44","doi-asserted-by":"publisher","first-page":"39182","DOI":"10.1074\/jbc.M112.372722","volume":"287","author":"MM Aynaud","year":"2012","unstructured":"Aynaud MM, Susp\u00e8ne R, Vidalain PO, Mussil B, Gu\u00e9tard D, Tangy F, et al. Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A. J Biol Chem. 2012;287:39182\u201392.","journal-title":"J Biol Chem"},{"key":"3550_CR45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjsurg.2013.02.002","volume":"205","author":"P Newell","year":"2013","unstructured":"Newell P, Cottam B, Savage T, Hammill C, Wolf R, Bifulco C, et al. Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach. Am J Surg. 2013;205:534\u201340.","journal-title":"Am J Surg"},{"key":"3550_CR46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799\u2013820.","journal-title":"Nat Rev Drug Discov"},{"key":"3550_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ccell.2024.03.010","volume":"42","author":"AN Hata","year":"2024","unstructured":"Hata AN, Larijani M. Targeting APOBECs in cancer: it\u2019s about timing. Cancer Cell. 2024;42:497\u2013501.","journal-title":"Cancer Cell"},{"key":"3550_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114099","volume":"386","author":"C Qu","year":"2025","unstructured":"Qu C, Kang X-Z, Li J, Kan X-Y, Luan Y, Ning D. Biomimetic lipid nanocarriers overcome hypoxia barriers in lung cancer therapy. J Control Release. 2025;386:114099.","journal-title":"J Control Release"},{"key":"3550_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113902","volume":"384","author":"A Gupta","year":"2025","unstructured":"Gupta A, Mahto S, Oberley Deegan RE, Coulter DW, Mahato RI. COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice. J Control Release. 2025;384:113902.","journal-title":"J Control Release"},{"key":"3550_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s44222-026-00401-1","volume":"4","author":"ML Arral","year":"2026","unstructured":"Arral ML, Whitehead KA. Design principles of lipid nanoparticles for RNA delivery. Nat Rev Bioeng. 2026;4:417\u201334.","journal-title":"Nat Rev Bioeng"},{"key":"3550_CR51","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1016\/j.apsb.2024.08.020","volume":"14","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu N, Gong L. An overview of the functions and mechanisms of APOBEC3A in tumorigenesis. Acta Pharm Sin B. 2024;14:4637\u201348.","journal-title":"Acta Pharm Sin B"},{"key":"3550_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2026.02.002","volume":"47","author":"S Li","year":"2026","unstructured":"Li S, Yang Y, Qiu H, Pang L. Macrophage heterogeneity and plasticity: mechanism and therapeutics. Trends Pharmacol Sci. 2026;47:537\u201354.","journal-title":"Trends Pharmacol Sci"},{"key":"3550_CR53","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li Z, Skrzypczynska KM, Fang Q, Zhang W, O\u2019Brien SA, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181:442\u201359.e29.","journal-title":"Cell"},{"key":"3550_CR54","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792\u2013809.e23.","journal-title":"Cell"},{"key":"3550_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2008","unstructured":"Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453\u201361.","journal-title":"Front Biosci"},{"key":"3550_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/1878-0261.12644","volume":"14","author":"H Dan","year":"2020","unstructured":"Dan H, Liu S, Liu J, Liu D, Yin F, Wei Z, et al. RACK1 promotes cancer progression by increasing the M2\/M1 macrophage ratio via the NF-\u03baB pathway in oral squamous cell carcinoma. Mol Oncol. 2020;14:795\u2013807.","journal-title":"Mol Oncol"},{"key":"3550_CR57","doi-asserted-by":"publisher","first-page":"e0170042","DOI":"10.1371\/journal.pone.0170042","volume":"12","author":"S Yin","year":"2017","unstructured":"Yin S, Huang J, Li Z, Zhang J, Luo J, Lu C, et al. The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: a meta-analysis. PLOS ONE. 2017;12:e0170042.","journal-title":"PLOS ONE"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03550-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03550-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03550-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:01:35Z","timestamp":1791270095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03550-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["3550"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03550-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Animal care and experiments were performed in accordance with protocols approved by the Institutional Laboratory Animal Care and Use Committee (IACUC). All animal experiments were approved by the IACUC of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2024-07-GLK-64).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}